QuantalX Neuroscience
1 known investors
Find your way into QuantalX Neuroscience
Sign up to see every warm intro you have to QuantalX Neuroscience
- Paths you didn't know you had: your email and LinkedIn already hold routes to the QuantalX Neuroscience team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
QuantalX develops Delphi-MD, an FDA De Novo-cleared diagnostic device that directly measures brain network function using targeted magnetic stimulation and electrophysiological recording analyzed by proprietary algorithms. The technology supports earlier detection, longitudinal monitoring, and clinical decision-making for neurological conditions, aimed at physicians and healthcare institutions.
Investors · 1
Frequently asked questions
- What does QuantalX Neuroscience do?
- QuantalX develops Delphi-MD, an FDA De Novo-cleared diagnostic device that directly measures brain network function using targeted magnetic stimulation and electrophysiological recording analyzed by proprietary algorithms. The technology supports earlier detection, longitudinal monitoring, and clinical decision-making for neurological conditions, aimed at physicians and healthcare institutions.
- Who are QuantalX Neuroscience's investors?
- QuantalX Neuroscience's investors include EMV Capital.
